# Study of MAP0010 in Asthmatic Children and Adolescents

> **NCT00697801** · PHASE2 · COMPLETED · sponsor: **Allergan** · enrollment: 208 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** MAP0010 low dose
- **DRUG:** MAP0010 high dose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00697801
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 208 (ACTUAL)
- **Last updated:** 2014-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00697801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00697801, "Study of MAP0010 in Asthmatic Children and Adolescents". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00697801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*